Eilmeldung
Senators and House Committees Urge NSF to Halt Dismantling of Ocean Monitoring NetworkSupreme Court to Decide if 6-Person Juries Violate Constitutional RightsAnthropic AI Shutdown Highlights Global Reliance on US TechAsylum Granted to Woman Adopted from Iran After Deportation ThreatBig Tech's AI Preemption Push Faces New Hurdles with Child Safety BillChild Dead, One Injured After Mississippi Officer Shoots at VehicleCountries Announce or Consider Social Media Bans for MinorsFederal immigration agent struck by vehicle in New JerseyPolitical Campaigns Grapple with Influencer Strategy's Mixed ResultsThe End of an Era: Apple's Intel Mac JourneySenators and House Committees Urge NSF to Halt Dismantling of Ocean Monitoring NetworkSupreme Court to Decide if 6-Person Juries Violate Constitutional RightsAnthropic AI Shutdown Highlights Global Reliance on US TechAsylum Granted to Woman Adopted from Iran After Deportation ThreatBig Tech's AI Preemption Push Faces New Hurdles with Child Safety BillChild Dead, One Injured After Mississippi Officer Shoots at VehicleCountries Announce or Consider Social Media Bans for MinorsFederal immigration agent struck by vehicle in New JerseyPolitical Campaigns Grapple with Influencer Strategy's Mixed ResultsThe End of an Era: Apple's Intel Mac Journey
Newsgather

licensing

Stabil40 Meldungen14 QuellenZuletzt aktualisiert: 4 g önce
Verwandte ThemenregulationHong Konghospitalityartificial intelligencenightlifeLondonalfresco diningClaire's

Neueste Meldungen

China’s Hengrui seals US$15.2 billion deal with US pharmaceutical giant BMS
NACHRICHT
12.05.2026

China’s Hengrui seals US$15.2 billion deal with US pharmaceutical giant BMS

Jiangsu Hengrui Pharmaceutical, China’s largest drug company by market capitalisation, has signed a global collaboration and licensing agreement with US pharmaceutical giant Bristol Myers Squibb (BMS) worth up to US$15.2 billion. Hengrui’s Hong Kong-traded shares climbed 5.3 per cent to HK$69.55 on Tuesday, while its Shenzhen stock rose 4.84 per cent to 56.11 yuan. The deal adds credibility to China’s growing reputation for innovative drug development. Industry players, however, said the country...

S
SCMP Economy
No hotpot: Hong Kong dog-friendly restaurants face menu and layout limits
NACHRICHT
11.05.2026

No hotpot: Hong Kong dog-friendly restaurants face menu and layout limits

Hong Kong restaurants applying for a licence that allows dogs to enter their premises will have to remove hotpot from their menus or change their eatery layouts to comply with regulations and ensure food and pet safety, authorities have said. The Food and Environmental Hygiene Department (FEHD) also said on Monday that officers would patrol the 1,000 licensed premises every day in the first month to inspect and understand their operations, provide advice and ensure compliance with licensing...

S
SCMP Economy